Takeda Biopharmaceuticals India Pvt Ltd. has appointed Annapurna Das as the General Manager for its operations in India. Annapurna brings over 20 years of extensive experience in the pharmaceutical and biotechnology sectors across India and Southeast Asia to her new role. Prior to joining Takeda, she held significant leadership roles in multinational healthcare firms such as Miltenyi Biotec, Sanofi, GSK, MSD, Pfizer, and Organon.
In her new capacity, Annapurna will spearhead Takeda’s initiatives in India, ensuring enhanced patient access to its innovative medicines and vaccines. She aims to foster valuable collaborations to address the diverse healthcare challenges prevalent in the country and contribute to the growth of the domestic healthcare and pharmaceutical market.
Expressing her enthusiasm for the role, Annapurna emphasized her commitment to serving patients in India by providing them with the best possible care through Takeda’s cutting-edge healthcare solutions. She looks forward to working closely with stakeholders and partners to strengthen Takeda’s presence in India and positively impact the lives of patients nationwide.
Dion Warren, Takeda’s Area Head for India and Southeast Asia, warmly welcomed Annapurna to the team, highlighting her wealth of experience and patient-centric approach. He expressed confidence in Annapurna’s strategic leadership, envisioning continued success and growth for Takeda in India. Warren emphasized Takeda’s dedication to fostering a diverse and inclusive workplace, aligned with its purpose and values, to create long-term value for patients and society.